Once we confirmed the expression status of EGFR and FAK in clinical samples, we evaluated the expression levels of EGFR, FAK and other molecules in human glioma cell lines both in vitro and in vivo with reference to the treatment effect of hUCBSC in these glioma cells. The gene discussed is PTK2; the disease is central nervous system cancer.